Belite Bio Inc ADR (BLTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -77,611 | -36,144 | -31,632 | -12,648 | -9,666 |
| Depreciation Amortization | 464 | 449 | 399 | 198 | 30 |
| Other Working Capital | 3,321 | 2,245 | -2,183 | -420 | 640 |
| Other Operating Activity | 36,838 | 4,216 | 3,579 | 1,412 | 1,522 |
| Operating Cash Flow | $-36,988 | $-29,234 | $-29,837 | $-11,458 | $-7,474 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -4,500 | N/A | N/A | N/A |
| PPE Investments | -178 | -116 | -63 | -394 | -56 |
| Purchase Of Investment | -451,994 | -183,765 | N/A | N/A | N/A |
| Sale Of Investment | 147,065 | 77,844 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -35 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -35 | 0 | 0 | 0 |
| Investing Cash Flow | $-305,107 | $-110,572 | $-63 | $-394 | $-56 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 546,209 | 83,201 | 77,189 | 37,993 | 232 |
| Other Financing Activity | 117,024 | 394 | -1,230 | -1,030 | -815 |
| Financing Cash Flow | $663,233 | $83,595 | $75,959 | $36,963 | $-583 |
| Exchange Rate Effect | 117 | -269 | 9 | -366 | -161 |
| Beginning Cash Position | 31,677 | 88,157 | 42,089 | 17,344 | 25,618 |
| End Cash Position | 352,932 | 31,677 | 88,157 | 42,089 | 17,344 |
| Net Cash Flow | $321,255 | $-56,480 | $46,068 | $24,745 | $-8,274 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,988 | -29,234 | -29,837 | -11,458 | -7,474 |
| Capital Expenditure | -178 | -116 | -63 | -394 | -74 |
| Free Cash Flow | -37,166 | -29,350 | -29,900 | -11,852 | -7,548 |